Epidemiological data on the prevalence of diseases and their risks is necessary in order to monitor the health of the population, and ultimately for medical practice. This applies in particular to cancer. To assess the incidence of cancer and thus cancer risks, cancer registries around the world have been making a significant contribution to research into the possible causes of cancer and its treatment for decades.
Since 1980, the canton of Zurich has maintained an epidemiological cancer registry at Institute of Pathology and Molecular Pathology of University Hospital Zurich in close collaboration with the Epidemiology, Biostatistics and Prevention Institute (EBPI) of the University of Zurich. Since 2011, the registry has also collected data for the canton of Zug. The collection of data on Zug cancer patients follows the objectives defined in the canton of Zug's Cancer Strategy 2010-2015.
The core task is to record, as far as possible, all new incidences of cancer among the population of both cantons Zurich and Zug. Thus, the cancer registry serves as an instrument to monitor the cancer burden among the population. This includes systematic and continuous collection of data, analysis, comparison and interpretation of data, and dissemination of the results through reporting.
Sabine Rohrmann, PhD, MPH
Head of the cancer registry